SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-003900
Filing Date
2015-04-24
Accepted
2015-04-24 16:43:30
Documents
5
Period of Report
2015-06-18
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224470zdef14a.htm DEF 14A 494970
2 G367710.JPG g367710.jpg GRAPHIC 8583
3 G507488.JPG g507488.jpg GRAPHIC 107597
4 G97642BCI001.GIF g97642bci001.gif GRAPHIC 90817
5 G97642BCI002.GIF g97642bci002.gif GRAPHIC 87393
  Complete submission text file 0001047469-15-003900.txt   902318
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35119 | Film No.: 15792305
SIC: 2834 Pharmaceutical Preparations